Expression of mHTT has also been shown to lower BECN1 levels and decrease autophagosome biogenesis, which is associated with enhanced mHTT aggregation, and the expression of BECN1 in the brain of human HD patients declines with age, supporting the importance of BECN1 in HD pathology [26–29]. This evidence concerns the gene BECN1 and Huntington disease.